Dose Finding Study of MCI-186 in Acute Ischemic Stroke
Status:
Terminated
Trial end date:
2018-05-14
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of MCI-186 (bolus followed by continuous infusion) in
acute ischemic stroke patients through a double-blind, parallel-group comparison with the
existing MCI-186 dosing regimen (administration twice daily for 14 days) as the control.